about
Obscurin-like 1, OBSL1, is a novel cytoskeletal protein related to obscurinCIP, a cardiac Isl1-interacting protein, represses cardiomyocyte hypertrophyLinker of nucleoskeleton and cytoskeleton complex proteins in cardiac structure, function, and disease.Lamina-associated polypeptide 2alpha loss impairs heart function and stress response in mice.Lamin A/C mutants disturb sumo1 localization and sumoylation in vitro and in vivo.Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.A G613A missense in the Hutchinson's progeria lamin A/C gene causes a lone, autosomal dominant atrioventricular block.LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studiesGENETIC CAUSES OF DILATED CARDIOMYOPATHY.Decoded calreticulin-deficient embryonic stem cell transcriptome resolves latent cardiophenotype.Collagen expression in fibroblasts with a novel LMNA mutationEmerging roles of sumoylation in the regulation of actin, microtubules, intermediate filaments, and septinsSpecific contribution of lamin A and lamin C in the development of laminopathies.Molecular basis of hereditary cardiomyopathy: abnormalities in calcium sensitivity, stretch response, stress response and beyond.The genetics of dilated cardiomyopathy.How cardiomyocytes sense pathophysiological stresses for cardiac remodeling.Lamin A/C Cardiomyopathies: Current Understanding and Novel Treatment Strategies.ALPK3 gene mutation in a patient with congenital cardiomyopathy and dysmorphic features.Measuring adriamycin-induced cardiac hemodynamic dysfunction with a proteomics approach.Variants of the lamin A/C (LMNA) gene in non-valvular atrial fibrillation patients: a possible pathogenic role of the Thr528Met mutation.Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers.Management of Bradyarrhythmias in Heart Failure: A Tailored Approach.LMNA-Mediated Arrhythmogenic Right Ventricular Cardiomyopathy and Charcot-Marie-Tooth Type 2B1: A Patient-Discovered Unifying Diagnosis.Altered Lamin A/C splice variant expression as a possible diagnostic marker in breast cancer.Age-related changes in lamin A/C expression in cardiomyocytes.
P2860
Q24296390-499C78F5-6184-4AC4-AAE1-C9A80247BA63Q28506542-ED1EA828-C08D-4026-AD60-9163A6B556A0Q33551452-640A04F1-EAC0-4AEF-B95F-C05B610897BCQ33639577-986027FB-5233-4371-A2C7-F43E26EFD695Q34430381-CEB080AC-F2AF-42F1-99A8-CB7991244570Q34446739-16688BC9-872E-4D71-BD67-DB4036EFC928Q34610236-E36D8AB0-F9AE-4FB2-91C8-FA791002FE3AQ34736236-7C9D74CE-ED5E-4932-8A4D-C4943BD3107FQ34881335-23173E55-FB69-40AF-A086-B994EBE1DBD4Q35086407-EDDA1DBC-BE5D-4E27-B916-B4614F9C3672Q35789656-111CE99C-57FA-4D02-9A00-AB6A2967157DQ37308644-F016309D-309F-4F3E-9D06-39E15860F5C2Q37603449-7A84F53F-BDF9-40C4-B3C0-6D5519912222Q37675919-B6096084-85F3-43C8-9B97-B31FEF8FA441Q37698904-14E57B26-73ED-439C-A68C-02FB6FD673FDQ38974621-2741A5FE-E72F-479A-8625-0A68884478B5Q39181367-88A8D80F-024B-4FC3-A695-2E6B537A393BQ39384466-2C07456F-268F-451D-91C3-8E6BBB28A12AQ43182896-F44804DC-A7EC-46C0-BF2D-E19C7CF321DAQ44507059-BC481B31-41FC-460E-9755-7F5FC472724FQ44991770-5F79F0CF-680D-4691-B141-A2523E1402B3Q47217272-14A36BD0-F0CF-4F7F-86D3-CD6B9AEA94C8Q51646628-FC452F14-0C30-42E1-BDC7-17DB17736887Q52890748-F846263A-9570-4EF1-8D27-ABD3A68DBA12Q53551848-54BAFD99-932C-4533-9601-7552B4B560ED
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Lamin A/C and cardiac diseases.
@ast
Lamin A/C and cardiac diseases.
@en
type
label
Lamin A/C and cardiac diseases.
@ast
Lamin A/C and cardiac diseases.
@en
prefLabel
Lamin A/C and cardiac diseases.
@ast
Lamin A/C and cardiac diseases.
@en
P1476
Lamin A/C and cardiac diseases.
@en
P2093
Frédérique Tesson
Nicolas Sylvius
P304
P356
10.1097/01.HCO.0000221575.33501.58
P577
2006-05-01T00:00:00Z